1. Relative effectiveness of the adjuvanted vs non-adjuvanted seasonal influenza vaccines against severe laboratory-confirmed influenza among hospitalized Italian older adults;Domnich;Int. J. Infect. Dis.,2022
2. ECDC, “Systematic review update on the efficacy, effectiveness and safety of newer and enhanced seasonal influenza vaccines for the prevention of laboratory confirmed influenza in individuals aged 18 years and over,” 2024, European Centre for Disease Prevention and Control, Stockholm. Accessed: April 10, 2024. Available: https://www.ecdc.europa.eu/sites/default/files/documents/Systematic%20review%20update%20enhanced%20seasonal%20flu%20vaccines-final-with-covers.pdf.
3. Investigating confounding in network-based test-negative design influenza vaccine effectiveness studies—experience from the DRIVE project;Stuurman;Influenza Other Respir. Viruses,2023
4. Innovative Medicines Initiative. DRIVE – development of robust and innovative vaccine effectiveness increasing understanding of influenza vaccine effectiveness in Europe. 2019. Accessed: August 30, 2019 Available: https://www.drive-eu.org/index.php/results/results-2018-19-season/.
5. Brand-specific influenza vaccine effectiveness estimates during 2019/20 season in Europe – results from the DRIVE EU study platform;Stuurman;Vaccine,2021